Medicare Watch articles are featured in a weekly newsletter that helps readers stay up-to-date on Medicare policy and advocacy developments, and learn about changes in Medicare benefits and rules.
In recent weeks, several committees within the U.S. House of Representatives—Energy & Commerce, Education & Labor, and Ways & Means—have been working to finalize the House’s drug pricing bill, HR 3. While the bill advanced by each committee differs slightly, the underlying goals are unchanged from the version initially introduced.
This month, five federal courts temporarily blocked a Trump administration final rule that would greatly harm families and prevent people
Some changes are in store for Part D in 2020 and policymakers are contemplating even more. The Kaiser Family Foundation (KFF), a nonpartisan nonprofit focused on national health issues, recently outlined what the program will look like next year under current law, and under recent legislative and administrative proposals.
Lawmakers in the U.S. House of Representatives are continuing work on their drug pricing bill, H.R. 3, with hopes of holding a vote later this month.
Unveiled in September, H.R. 3 includes a number of provisions that would improve prescription drug access and affordability for people with Medicare. Among the bill’s critical reforms are those allowing Medicare to negotiate drug prices; the imposition of inflationary rebates on certain drugs in Parts B and D; and a restructuring of the Part D benefit that would cap out-of-pocket costs, reduce the federal government’s liability, and better align pricing incentives.
The Social Security Administration announced today that the cost-of-living adjustment (COLA) for 2020 will be 1.6%. The COLA is the mechanism that keeps Social Security benefits in line with inflation. As the cost of living increases, so do Social Security benefits.
Last week, the Trump Administration released a wide-ranging yet ambiguous Executive Order (EO) focused on the Medicare program.
Many of the EO provisions lack specifics, making it difficult to predict what, if any, policies or recommendations may emerge. Since any policies that do emerge would likely require legislative or regulatory action before taking effect, the EO’s prospects for impacting the program are also unknown.
Currently, Medicare does not cover most dental services. The Kaiser Family Foundation (KFF), a non-partisan, non-profit focused on national health issues, recently released an issue brief discussing various options to increase access to dental coverage for people with Medicare. According to the brief, nearly two out of every three Medicare beneficiaries have no dental coverage, leading many to go without necessary care.
This week, Rep. Brad Schneider (D-IL) introduced a House companion to the Medicare Extra Rx HELP Act (S. 691/H.R. 4583). Championed in the Senate by Bob Casey (D-PA), this bill would make improvements to the Medicare Part D Low-Income Subsidy (LIS), commonly known as Extra Help, to better reflect current needs.
Last week, Senator Bob Casey (D-PA), along with Representatives. Lloyd Doggett (D-TX) and Brian Fitzpatrick (R-PA) introduced legislation to improve the health and economic security of people with disabilities—the Stop the Wait Act (S. 2496, H.R. 4386).
Last week, U.S. House of Representatives Speaker Nancy Pelosi (D-CA) released her much-anticipated drug pricing plan, the Lower Drug Costs Now Act of 2019 (H.R. 3). Top Democrats on the three committees of jurisdiction introduced the legislation—Chairman Frank Pallone (D-NJ), Energy & Commerce; Chairman Richard Neal (D-MA), Ways & Means; and Chairman Bobby Scott (D-VA), Education & Labor.
In recent weeks, several committees within the U.S. House of Representatives—Energy & Commerce, Education & Labor, and Ways & Means—have been working to finalize the House’s drug pricing bill, HR 3. While the bill advanced by each committee differs slightly, the underlying goals are unchanged from the version initially introduced.
This month, five federal courts temporarily blocked a Trump administration final rule that would greatly harm families and prevent people
Some changes are in store for Part D in 2020 and policymakers are contemplating even more. The Kaiser Family Foundation (KFF), a nonpartisan nonprofit focused on national health issues, recently outlined what the program will look like next year under current law, and under recent legislative and administrative proposals.
Lawmakers in the U.S. House of Representatives are continuing work on their drug pricing bill, H.R. 3, with hopes of holding a vote later this month.
Unveiled in September, H.R. 3 includes a number of provisions that would improve prescription drug access and affordability for people with Medicare. Among the bill’s critical reforms are those allowing Medicare to negotiate drug prices; the imposition of inflationary rebates on certain drugs in Parts B and D; and a restructuring of the Part D benefit that would cap out-of-pocket costs, reduce the federal government’s liability, and better align pricing incentives.
The Social Security Administration announced today that the cost-of-living adjustment (COLA) for 2020 will be 1.6%. The COLA is the mechanism that keeps Social Security benefits in line with inflation. As the cost of living increases, so do Social Security benefits.
Last week, the Trump Administration released a wide-ranging yet ambiguous Executive Order (EO) focused on the Medicare program.
Many of the EO provisions lack specifics, making it difficult to predict what, if any, policies or recommendations may emerge. Since any policies that do emerge would likely require legislative or regulatory action before taking effect, the EO’s prospects for impacting the program are also unknown.
Currently, Medicare does not cover most dental services. The Kaiser Family Foundation (KFF), a non-partisan, non-profit focused on national health issues, recently released an issue brief discussing various options to increase access to dental coverage for people with Medicare. According to the brief, nearly two out of every three Medicare beneficiaries have no dental coverage, leading many to go without necessary care.
This week, Rep. Brad Schneider (D-IL) introduced a House companion to the Medicare Extra Rx HELP Act (S. 691/H.R. 4583). Championed in the Senate by Bob Casey (D-PA), this bill would make improvements to the Medicare Part D Low-Income Subsidy (LIS), commonly known as Extra Help, to better reflect current needs.
Last week, Senator Bob Casey (D-PA), along with Representatives. Lloyd Doggett (D-TX) and Brian Fitzpatrick (R-PA) introduced legislation to improve the health and economic security of people with disabilities—the Stop the Wait Act (S. 2496, H.R. 4386).
Last week, U.S. House of Representatives Speaker Nancy Pelosi (D-CA) released her much-anticipated drug pricing plan, the Lower Drug Costs Now Act of 2019 (H.R. 3). Top Democrats on the three committees of jurisdiction introduced the legislation—Chairman Frank Pallone (D-NJ), Energy & Commerce; Chairman Richard Neal (D-MA), Ways & Means; and Chairman Bobby Scott (D-VA), Education & Labor.
